The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: endoxan     Quarter: 2016Q3

Total Drug/Injury Combinations: 404     Number of Pages: 21

DRUGNAME PT EventCount
ENDOXAN Renal impairment 3 view events
ENDOXAN /00021101/ Febrile bone marrow aplasia 3 view events
ENDOXAN 1000 MG, POUDRE POUR SOLUTION INJECTABLE Abdominal pain 3 view events
ENDOXAN 1000 MG, POUDRE POUR SOLUTION INJECTABLE Acute kidney injury 3 view events
ENDOXAN 1000 MG, POUDRE POUR SOLUTION INJECTABLE Acute prerenal failure 3 view events
ENDOXAN 1000 MG, POUDRE POUR SOLUTION INJECTABLE Adenocarcinoma of colon 3 view events
ENDOXAN 1000 MG, POUDRE POUR SOLUTION INJECTABLE Bone marrow failure 3 view events
ENDOXAN 1000 MG, POUDRE POUR SOLUTION INJECTABLE Dehydration 3 view events
ENDOXAN 1000 MG, POUDRE POUR SOLUTION INJECTABLE Diabetes mellitus inadequate control 3 view events
ENDOXAN 1000 MG, POUDRE POUR SOLUTION INJECTABLE Febrile bone marrow aplasia 3 view events
ENDOXAN 1000 MG, POUDRE POUR SOLUTION INJECTABLE Hepatic steatosis 3 view events
ENDOXAN 1000 MG, POUDRE POUR SOLUTION INJECTABLE Hepatocellular injury 3 view events
ENDOXAN 1000 MG, POUDRE POUR SOLUTION INJECTABLE Jaundice cholestatic 3 view events
ENDOXAN 1000 MG, POUDRE POUR SOLUTION INJECTABLE Lung disorder 3 view events
ENDOXAN 1000 MG, POUDRE POUR SOLUTION INJECTABLE Pancytopenia 3 view events
Endoxan 500mg inj. (cyclophosphamide) Therapy non-responder 3 view events
Endoxan Lyophilisat Drug resistance 3 view events
Endoxan Lyophilisat General physical health deterioration 3 view events
Endoxan Lyophilisat Viral load increased 3 view events
ENDOXAN Acute prerenal failure 2 view events

Total Drug/Injury Combinations: 404     Number of Pages: 21

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)